Anthem Biosciences Limited (NSE: ANTHEM) stock cleared its 6M resistance trendline and is up 5% intraday at ₹896.8.
Anthem Biosciences Limited (NSE: ANTHEM) stock price falls 5% intraday to ₹746.1, breaking below support in a sectoral breakdown..
Anthem Biosciences Limited (NSE: ANTHEM) announces investor presentation on July 21, 2026, highlighting strategic updates and financial performance.
Anthem Biosciences Limited (NSE: ANTHEM) investor presentation highlights strong Q1FY27 performance with robust margins and promising future outlook.
Anthem Biosciences Limited (NSE: ANTHEM) announced its Q4 FY26 results with a 26% YoY revenue growth and a 129.8% surge in PAT.